Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends in dermatologic surgery research over the past decade.
Akerman L, Hodak E, Pavlovsky L, Mimouni FB, David M, Mimouni D. Akerman L, et al. Among authors: pavlovsky l. Eur J Dermatol. 2010 Mar-Apr;20(2):196-9. doi: 10.1684/ejd.2010.0880. Epub 2010 Feb 19. Eur J Dermatol. 2010. PMID: 20167567
Phototherapy of Mycosis Fungoides.
Hodak E, Pavlovsky L. Hodak E, et al. Among authors: pavlovsky l. Dermatol Clin. 2015 Oct;33(4):697-702. doi: 10.1016/j.det.2015.05.005. Epub 2015 Aug 1. Dermatol Clin. 2015. PMID: 26433842 Free article. Review.
Biologic drug survival in Israeli psoriasis patients.
Shalom G, Cohen AD, Ziv M, Eran CB, Feldhamer I, Freud T, Berman E, Oren S, Hodak E, Pavlovsky L. Shalom G, et al. Among authors: pavlovsky l. J Am Acad Dermatol. 2017 Apr;76(4):662-669.e1. doi: 10.1016/j.jaad.2016.10.033. Epub 2016 Dec 28. J Am Acad Dermatol. 2017. PMID: 28038888
The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-life Clinical Data.
Amitay-Laish I, Guenova E, Ortiz-Romero PL, Vico-Alonso C, Rozati S, Geskin LJ, Nikolaou V, Papadavid E, Barzilai A, Pavlovsky L, Didkovsky E, Naveh HP, Akilov OE, Hodak E. Amitay-Laish I, et al. Among authors: pavlovsky l. Acta Derm Venereol. 2020 Sep 30;100(16):adv00277. doi: 10.2340/00015555-3642. Acta Derm Venereol. 2020. PMID: 32965506 Free PMC article.
Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic.
Yanai H, Amir Barak H, Ollech JE, Avni Biron I, Goren I, Snir Y, Banai Eran H, Broitman Y, Aharoni Golan M, Didkovsky E, Amitay-Laish I, Ollech A, Hodak E, Dotan I, Pavlovsky L. Yanai H, et al. Among authors: pavlovsky l. Ther Adv Gastroenterol. 2021 Nov 8;14:17562848211053112. doi: 10.1177/17562848211053112. eCollection 2021. Ther Adv Gastroenterol. 2021. PMID: 34777576 Free PMC article.
Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature.
Reiss-Huss S, Hilewitz D, Yacobovitz S, Matar M, Weintraub Y, Shouval DS, Topf-Olivestone C, Pavlovsky L, Tal R, Amarilyo G, Renert-Yuval Y, Friedland R. Reiss-Huss S, et al. Among authors: pavlovsky l. Arch Dermatol Res. 2025 Jun 6;317(1):799. doi: 10.1007/s00403-025-04300-0. Arch Dermatol Res. 2025. PMID: 40481366 Free PMC article. Review.
Trends in pemphigus research over 15 years.
Leshem YA, Pavlovsky L, Mimouni FB, David M, Mimouni D. Leshem YA, et al. Among authors: pavlovsky l. J Eur Acad Dermatol Venereol. 2010 Feb;24(2):173-7. doi: 10.1111/j.1468-3083.2009.03390.x. Epub 2009 Aug 14. J Eur Acad Dermatol Venereol. 2010. PMID: 19686325
[Psoriasis and cardiovascular risk factors].
Tal R, Pavlovsky L, David M. Tal R, et al. Among authors: pavlovsky l. Harefuah. 2012 Oct;151(10):573-5, 605. Harefuah. 2012. PMID: 23316664 Review. Hebrew.
Trends in dermatology publications over the past 15 years.
Mimouni D, Pavlovsky L, Akerman L, David M, Mimouni FB. Mimouni D, et al. Among authors: pavlovsky l. Am J Clin Dermatol. 2010;11(1):55-8. doi: 10.2165/11530190-000000000-00000. Am J Clin Dermatol. 2010. PMID: 20000876
Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice.
Khobzey K, Liskova I, Szegedi A, Pavlovsky L, Lunder T, Kingo K, Miljković J, Péč J, Bohinc M, Hojnik M. Khobzey K, et al. Among authors: pavlovsky l. Acta Dermatovenerol Alp Pannonica Adriat. 2017 Mar;26(1):11-14. doi: 10.15570/actaapa.2017.3. Acta Dermatovenerol Alp Pannonica Adriat. 2017. PMID: 28352929 Free article.
Systemic Biologic Treatment for Psoriasis in Elderly Patients.
Glazer Levavi S, Maman R, Sherman S, Mimouni D, Pavlovsky L. Glazer Levavi S, et al. Among authors: pavlovsky l. J Clin Med. 2025 Jul 7;14(13):4779. doi: 10.3390/jcm14134779. J Clin Med. 2025. PMID: 40649154 Free PMC article.
Reply.
Shalev Rosenthal Y, Schwartz N, Sagy I, Pavlovsky L. Shalev Rosenthal Y, et al. Among authors: pavlovsky l. Arthritis Rheumatol. 2022 Aug;74(8):1451-1452. doi: 10.1002/art.42123. Epub 2022 Jun 6. Arthritis Rheumatol. 2022. PMID: 35315255 No abstract available.
Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.
Warren RB, Pavlovsky L, Costanzo A, Bukhalo M, Korman NJ, Huang YH, Kokolakis G, Pinter A, Ibrahim N, Zheng Y, Drogaris L, Stakias V, Soliman AM, Rubant S, Thaçi D. Warren RB, et al. Among authors: pavlovsky l. Dermatol Ther (Heidelb). 2025 Feb;15(2):477-481. doi: 10.1007/s13555-024-01328-4. Dermatol Ther (Heidelb). 2025. PMID: 39821856 Free PMC article. No abstract available.
Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.
Warren RB, Pavlovsky L, Costanzo A, Bukhalo M, Korman NJ, Huang YH, Kokolakis G, Pinter A, Ibrahim N, Zheng Y, Drogaris L, Stakias V, Soliman AM, Rubant S, Thaçi D. Warren RB, et al. Among authors: pavlovsky l. Dermatol Ther (Heidelb). 2024 Dec;14(12):3273-3290. doi: 10.1007/s13555-024-01292-z. Epub 2024 Nov 8. Dermatol Ther (Heidelb). 2024. PMID: 39516454 Free PMC article.
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO).
Piaserico S, Riedl E, Pavlovsky L, Vender RB, Mert C, Tangsirisap N, Haustrup N, Gallo G, Schuster C, Brunner PM. Piaserico S, et al. Among authors: pavlovsky l. Front Med (Lausanne). 2023 Jun 29;10:1185523. doi: 10.3389/fmed.2023.1185523. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37457564 Free PMC article.
Effectiveness, Quality of Life and Durability of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Real-World Evidence from the PRIMMA Study.
Snast I, Valdman-Grinshpoun Y, Bathish N, Matz H, Shclar Y, Murad S, Czarnowicki T, Shavit E, Yang L, Goss S, Maor IP, Halperin A, Blonder SN, Cohen R, Bleterman A, Barak M, Pavlovsky L. Snast I, et al. Among authors: pavlovsky l. Dermatol Ther (Heidelb). 2026 May;16(5):2525-2540. doi: 10.1007/s13555-026-01729-7. Epub 2026 Mar 31. Dermatol Ther (Heidelb). 2026. PMID: 41915361 Free PMC article.
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse).
Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, Papp KA. Stein Gold LF, et al. Among authors: pavlovsky l. Br J Dermatol. 2023 Oct 25;189(5):540-552. doi: 10.1093/bjd/ljad252. Br J Dermatol. 2023. PMID: 37488811 Free PMC article. Clinical Trial.
Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network.
Wolf P, Ceovic R, Conrad C, Falkensteiner K, Graier T, Kołt-Kamińska M, Marovt M, Mateeva V, Maul JT, Navarini AA, Nicolescu AC, Ratzinger G, Pavlovsky L, Sanzharovskaya M, Szegedi A, Reich A. Wolf P, et al. Among authors: pavlovsky l. J Eur Acad Dermatol Venereol. 2024 Aug;38(8):1531-1542. doi: 10.1111/jdv.19808. Epub 2024 Jan 27. J Eur Acad Dermatol Venereol. 2024. PMID: 38279888
Global Delphi consensus on treatment goals for generalized pustular psoriasis.
Barker JN, Casanova E, Choon SE, Foley P, Fujita H, Gonzalez C, Gooderham M, Marrakchi S, Puig L, Romiti R, Thaçi D, Zheng M, Strober B; Partnering for Innovation and Excellence in Rare Skin Diseases (PIONEERS®) Working Group and the DELPHI Panel. Barker JN, et al. Br J Dermatol. 2025 Mar 18;192(4):706-716. doi: 10.1093/bjd/ljae491. Br J Dermatol. 2025. PMID: 39844356 Free article.
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study.
Caron AGM, van Huizen AM, Musters AAH, Gerbens LAA, Middelkamp Hup MA, Flohr C, Irvine AD, Vestergaard C, Peris K, Brandling-Bennett HA, Drucker AM, Spuls PI; MTX Consensus for AD Survey Study Group. Caron AGM, et al. J Eur Acad Dermatol Venereol. 2025 Feb;39(2):331-339. doi: 10.1111/jdv.20271. Epub 2024 Aug 1. J Eur Acad Dermatol Venereol. 2025. PMID: 39087636 Free PMC article.
Negative influence of biofilm on CoCrMo corrosion.
Chuang PJ, Swaminathan V, Pavlovsky L, Marquez-Catral L, Jones DL, Song L. Chuang PJ, et al. Among authors: pavlovsky l. J Biomed Mater Res A. 2019 Nov;107(11):2556-2566. doi: 10.1002/jbm.a.36761. Epub 2019 Aug 8. J Biomed Mater Res A. 2019. PMID: 31355999
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.